PHAR Pharming Group
- 10.150
- +0.260+2.63%
- 10.150
- 0.0000.00%
Pharming Group News
Pharming Group | 6-K: Report of foreign private issuer (related to financial reporting)
Pharming Group | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Pharming Group | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RTW Investments, LP(0%),Roderick Wong, M.D.(0%)
Pharming Group | SC 13G: Statement of acquisition of beneficial ownership by individuals-Morgan Stanley(6.5%)
Pharming Group | 6-K: Report of foreign private issuer (related to financial reporting)
Pharming Group | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Pharming Group | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Pharming Group | 6-K: Report of foreign private issuer (related to financial reporting)
Pharming Group | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Pharming Group | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Pharming Group | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Pharming Group | 6-K: Report of foreign private issuer (related to financial reporting)
Pharming Group | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Pharming Group | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Pharming Group | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Pharming Group | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Pharming Group | 20-F: FY2023 Annual Report
Pharming Group | 6-K: Report of foreign private issuer (related to financial reporting)
Pharming Group | SC 13G: Statement of acquisition of beneficial ownership by individuals-RTW Investments, LP(5.8%),Roderick Wong, M.D.(5.8%)
Pharming Group | 6-K: Report of foreign private issuer (related to financial reporting)
No Data